Drug Delivery · London, United Kingdom · Founded 2021 · Privately Held (backing)
Developer of women-specific drug-delivery systems designed to improve patient outcomes. Calla Lily Clinical Care is based in London, United Kingdom and was founded in 2021. Its last reported valuation was $14.4 million in Jan 2025. It has raised $6.9 million across 1 recorded round; the latest was an accelerator round in Mar 2025.
Last reported valuation
$14.4M
Oct 2026
Priced at
—
Total raised
$6.9M
Last round
Accelerator/Incubator
Mar 2025
Team — not yet on record
No current team members for Calla Lily Clinical Care are on record yet. People surface from round filings, company disclosures, and coverage sessions.
Pro members can request priority coverage with a 48-hour turnaround.
Free account
More of Calla Lily Clinical Care with a free account
·Watch Calla Lily Clinical Care: the Monday email on marks, rounds and moves
